Fast Company | Can a new wave of male fertility startups democratize family planning?

Fast Company logo

Sperm testing does more than just highlight reproductivity–it also detects greater biological markers. Numerous studies attest to sperm count as a biomarker for overall health. If a man has low sperm count, he has a higher likelihood of having or developing some other health condition. In many ways, Trak sees itself fulfilling a bigger need.

“We are reaching this young demographic of men that aren’t seeing a doctor, and fertility is really a strong motivator for these guys,” says Greg Sommer, Trak’s Chief Scientific Officer. With the objective of better sperm, Trak advises men to stop smoking or eat more whole foods, among other directives. “It puts young men on the road to a healthier life.”

See Trak featured in Fast Company!